The results showed that HER2 CAR-Ms and CD47 CAR-Ms significantly inhibited tumorigenicity and tumor proliferation of ovarian cancer cell lines, confirming CAR-mediated phagocytosis of macrophages on ovarian cancer cells (Chen et al., 2023). Here, ERBB2 is linked to neoplasm.